Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
CPRX
#1635
Catalyst Pharmaceutical Inc.
26.190
0
USD
+3.35%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+3.35%
Aylık Değişim
+12.11%
6 aylık değişim
+23.48%
Yıllık Değişim
+23.48%
Önceki Kapanış
25.340
0
Open
26.190
0
Bid
Ask
Low
26.190
0
High
26.190
0
Hacim
116
Piyasalar
ABD Borsası
Sağlık Hizmetleri
CPRX
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
103.82 M
102.74 M
105.65 M
117.86 M
121.45 M
122.12 M
—
Valuation ratios
Enterprise value
216.54 M
524.14 M
1.61 B
1.88 B
2.02 B
2.14 B
8.25 B
Price to earnings ratio
4.7
18.3
24.08
27.16
15.93
13.89
53.94
Price to sales ratio
2.98
5.18
9.39
4.89
5.3
5.04
19.96
Price to cash flow ratio
7.88
12.09
17.33
13.55
10.87
14.23
46.16
Price to book ratio
2.09
3.53
6.7
5.02
3.58
3.11
5.86
Enterprise value to EBITDA ratio
5.23
9.97
15.79
15.7
7.46
6.43
24.17
Profitability ratios
Return on assets %
0.39
0.17
0.22
0.15
0.19
0.19
0.21
Return on equity %
0.44
0.19
0.28
0.18
0.23
0.22
0.24
Return on invested capital %
1 733.34
516.79
783.31
168.59
244.3
327.89
344.62
Gross margin %
85.69
84.46
83.94
86.95
86
85.19
340.92
Operating margin %
34.69
37.2
47.54
21.8
39.68
43.77
175.22
EBITDA margin %
34.76
37.33
47.61
30.06
54.96
56.56
263.78
Net margin %
62.97
28.03
38.79
17.93
33.33
36.39
145.77
Liquidity ratios
Quick ratio
6.79
7.47
5.45
2.68
5.01
5.82
24.74
Current ratio
7
7.76
5.57
2.88
5.17
6.08
25.55
Inventory turnover
5.16
3.5
4.69
4.63
3.91
3.08
3.75
Asset turnover
0.78
0.65
0.7
0.94
0.74
0.6
0.6
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.42
0.56
1.04
1.26
1.92
1.64
1.64
EBIT per share
0.39
0.49
0.9
0.76
1.86
2.32
2.32
EBITDA per share
0.39
0.49
0.92
1.05
2.16
2.62
3.06
Total debt per share
—
—
—
—
—
—
—
Cash per share
1.32
1.77
2.68
1.21
4.14
5.57
20.69
Net current asset value per share
1.5
1.95
2.88
1.93
4.99
7.03
25.08
Tangible book value per share
1.6
1.92
2.41
1.7
4.57
6.46
23.42
Working capital per share
1.28
1.7
2.36
1.26
4.03
5.87
21.15
Book value per share
1.6
1.92
2.7
3.41
5.82
7.5
27.71
Haberler
KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug
RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data
ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study
Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes
SNY & REGN's Dupixent Gets EU Approval for Pediatric Use in Urticaria
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200
If You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have Now
ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know
Recent Price Trend in Catalyst (CPRX) is Your Friend, Here's Why
Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why
Insmed Ends Brinsupri Development in Skin Disease Post Study Failure